000 01105 a2200277 4500
005 20250517061510.0
264 0 _c20160912
008 201609s 0 0 eng d
022 _a1558-1365
024 7 _a10.1016/j.coms.2015.06.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWilliams, William Bradford
245 0 0 _aManagement of Medication-Related Osteonecrosis of the Jaw.
_h[electronic resource]
260 _bOral and maxillofacial surgery clinics of North America
_cNov 2015
300 _a517-25 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBisphosphonate-Associated Osteonecrosis of the Jaw
_xtherapy
650 0 4 _aBone Density Conservation Agents
_xadverse effects
650 0 4 _aDenosumab
_xadverse effects
650 0 4 _aDiphosphonates
_xadverse effects
650 0 4 _aDisease Progression
650 0 4 _aHumans
700 1 _aO'Ryan, Felice
773 0 _tOral and maxillofacial surgery clinics of North America
_gvol. 27
_gno. 4
_gp. 517-25
856 4 0 _uhttps://doi.org/10.1016/j.coms.2015.06.007
_zAvailable from publisher's website
999 _c25401087
_d25401087